Prostacyclin-to-thromboxane A2 ratio in arteriogenic impotence. 1990

S C Kim, and I G Choi, and C H Oh, and Y J Cha
Department of Urology, College of Medicine, Chung-Ang University, Seoul, Korea.

It has been suggested that penile hypercoagulability predisposes to aging penile vascular changes and impotence, and that elevated thromboxane A2 during erection may contribute to hypercoagulability and atherosclerosis. Since the ratio of the prostacyclin concentration to the thromboxane A2 concentration is constantly maintained in normal hemostatic responses, an imbalance between thromboxane A2 and prostacyclin may be a factor to initiate vascular diseases and decrease blood flow. We assess the usefulness of the prostacyclin-to-thromboxane A2 ratio in penile blood during erection for diagnosis of arteriogenic impotence. The ratio in the arteriogenic impotence group was significantly lower (p less than 0.01) than in the psychogenic and venogenic impotence groups. Therefore, the prostacyclin-to-thromboxane A2 ratio seems to be useful to diagnose arteriogenic impotence.

UI MeSH Term Description Entries
D007172 Erectile Dysfunction The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction. Impotence,Male Impotence,Male Sexual Impotence,Dysfunction, Erectile,Impotence, Male,Impotence, Male Sexual,Sexual Impotence, Male
D008297 Male Males
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

S C Kim, and I G Choi, and C H Oh, and Y J Cha
July 1986, Kardiologiia,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
December 1990, Clinical and investigative medicine. Medecine clinique et experimentale,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
November 1999, Prostaglandins & other lipid mediators,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
June 1986, Danish medical bulletin,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
January 1980, Ciba Foundation symposium,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
January 1994, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
April 2002, Science (New York, N.Y.),
S C Kim, and I G Choi, and C H Oh, and Y J Cha
January 1982, Advances in prostaglandin, thromboxane, and leukotriene research,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
S C Kim, and I G Choi, and C H Oh, and Y J Cha
September 1984, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!